XRCC1 and xeroderma pigmentosum-Cockayne syndrome complex: A number of genetic variants have been reported to be associated with radiotherapy response for cancer, including XRCC1, X-ray repair cross complementing 2 (XRCC2), xeroderma pigmentosum group D (XPD), and EGFR [15, 16].